Literature DB >> 34605986

Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson's disease.

Xiao-Tong Wang1, Feng-Tao Liu2, Huan Yu2, Can Zhang3, Ya-Hui Ma1, Jian Wang2, Qiang Dong2, Lan Tan4, Han Wang5, Jin-Tai Yu6.   

Abstract

OBJECTIVES: Our aim is to investigate the associations of sleep disorders with cerebrospinal fluid (CSF) α-synuclein (α-syn) in healthy controls (HCs), and patients with prodromal and early Parkinson's disease (PD).
METHODS: We included a total of 575 individuals, consisting of 360 PD individuals, 46 prodromal PD individuals, and 169 HCs. Multiple linear regression models and linear mixed-effects models were used to investigate the associations of sleep disorders with baseline and longitudinal CSF α-syn. Associations between the change rates of sleep disorders and CSF α-syn were further investigated via multiple linear regression models.
RESULTS: In PD, probable Rapid-eye-movement sleep Behavior Disorder (pRBD) (β = - 0.1199; P = 0.0444) and RBD sub-items, such as aggressive dreams (β = - 0.1652; P = 0.0072) and hurting bed partner (β = - 0.2468; P = 0.0010), contributed to lower CSF α-syn. The association between aggressive dreams and lower CSF α-syn further survived Bonferroni correction (P < 0.0036). In prodromal PD, dream-enacting (a specific RBD behavior) was significantly associated with decreased CSF α-syn during the follow-up (β = - 0.0124; P = 0.0237). HCs with daytime sleepiness when inactive-sitting in public places (β = - 0.0033; P = 0.0135) showed decreased CSF α-syn. Furthermore, increased possibilities of daytime sleepiness when sitting and reading contributed to a greater decrease of CSF α-syn in HCs (β = - 196.8779; P = 0.0433).
CONCLUSIONS: Sleep disorders were associated with decreased CSF α-syn. Sleep management may be important for disease monitoring and preventing the progression of α-syn pathology.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cerebrospinal fluid; Parkinson’s disease; Sleep disorders; α-Synuclein

Mesh:

Substances:

Year:  2021        PMID: 34605986     DOI: 10.1007/s00415-021-10812-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  3 in total

1.  Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson's Disease.

Authors:  Jiangnan Ma; Kaixin Dou; Ruize Liu; Yajin Liao; Zengqiang Yuan; Anmu Xie
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

2.  Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases.

Authors:  Shaoping Zhong; Yangye Lian; Wenyi Luo; Rongkui Luo; Xiaoling Wu; Jun Ji; Yuan Ji; Jing Ding; Xin Wang
Journal:  Acta Neuropathol       Date:  2021-10-25       Impact factor: 17.088

3.  Sex differences in clinical cognitive impairment with Lewy bodies: a Chinese multicenter study.

Authors:  Jinghuan Gan; Zhichao Chen; Zhihong Shi; Xudong Li; Shuai Liu; Yiming Liu; Hongcan Zhu; Lu Shen; Guili Zhang; Yong You; Qihao Guo; Nan Zhang; Yang Lv; Baozhi Gang; Junliang Yuan; Yong Ji
Journal:  Biol Sex Differ       Date:  2022-10-01       Impact factor: 8.811

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.